If you have colon cancer, specifically stage 3 dMMR, your doctor may choose to prescribe TECENTRIQ + chemotherapy after surgery. Be sure to talk together about the best plan for you.
TECENTRIQ is a type of cancer immunotherapy that can help reactivate the immune system so it can recognize cancer cells in the body. It is different than chemotherapy. TECENTRIQ is an anti-PD-L1 antibody, designed to block PD-L1 and reveal cancer cells. This process helps the immune system attack and destroy the cancer. TECENTRIQ may also affect normal cells. When it comes to colon cancer, TECENTRIQ is given after surgery in combination with chemotherapy if you are stage 3 and are positive for the biomarker dMMR. You should have a discussion with your doctor if you are considering cancer immunotherapy treatment.
If your doctor suggests additional treatment after surgery, that does not mean that the procedure was unsuccessful. After surgery, though, there may be hidden microscopic cancer cells remaining that surgery cannot reach. Adding TECENTRIQ to your treatment regimen may prevent your cancer from coming back.
There are many underlying causes that allow cancer to develop and grow. Different medicines target these different causes.
Depending on how you are responding to treatment, your oncologist will come up with a plan. TECENTRIQ has flexible dosing options and can be given every 2, 3, or 4 weeks. Treatment is usually given over the course of 1 year. Together, you and your doctor can decide which treatment schedule is best for you.
Your oncologist will monitor your progress while you take TECENTRIQ. They will use tests and scans to see how you are responding to treatment.
There are potential side effects that can occur with TECENTRIQ, as well as chemotherapy.
The most common side effects of TECENTRIQ when used alone include:
Talk to your doctor about what to expect with either treatment. If you experience any symptoms while taking your medicines, it’s a good idea to take note of them and discuss them with your doctor to consider how to treat them. TECENTRIQ can cause serious side effects. These can sometimes become severe or life-threatening and can lead to death.
TECENTRIQ is covered by many commercial insurance plans, but coverage can vary. Your oncologist’s office can help you determine whether your plan provides coverage. There may be options to help you afford your TECENTRIQ, no matter what type of health insurance you have. For more information about our programs and services, visit gene.com/patients/medicines/tecentriq or call (888) 249-4918.
If you have questions or concerns about TECENTRIQ, your diagnosis, or your treatments, you should discuss them with your healthcare team. You can also call us at (877) 436-3683.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.